Literature DB >> 33520863

Gut microbiota: a perspective of precision medicine in endocrine disorders.

Salman Shirvani Rad1,2, Amirabbas Nikkhah3, Mohammadmahdi Orvatinia3, Hanieh-Sadat Ejtahed4,5, Negar Sarhangi2, Seyed Hamid Jamaldini6, Nazli Khodayari7, Hamid Reza Aghaei Meybodi2, Mandana Hasanzad2,6.   

Abstract

Gut microbiota composition is unique in every individual, it impacts on organ functions that produce hormones. Gut microbiota composition balance is directly related to our general health status. This continual interaction between gut microbiota and endocrine organs sometimes can be considered as the etiology of diseases such as type 2 diabetes mellitus (T2DM), obesity, osteoporosis, polycystic ovary syndrome (PCOS), and thyroid diseases. Microbiota is introduced for a total collection of microbial organisms in our bodies and microbiome referred for their genome and their collective functions. Near 100 trillion microorganisms live in our body and almost all of them occupy the human gut gastrointestinal tract. Precision medicine can play a crucial role in health maintenance by affecting gut microbiota composition in every individual. It can also develop special treatments specifically for every individual. In this review, we addressed any correlation between gut microbiota and endocrine disorders including T2DM, obesity, PCOS, thyroid disorders and osteoporosis. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  Endocrine disorders; Gut microbiota; Microbiome; Precision medicine

Year:  2020        PMID: 33520863      PMCID: PMC7843755          DOI: 10.1007/s40200-020-00593-2

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  78 in total

Review 1.  Commensal host-bacterial relationships in the gut.

Authors:  L V Hooper; J I Gordon
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

Review 2.  Immunity, thyroid function and pregnancy: molecular mechanisms.

Authors:  Anthony P Weetman
Journal:  Nat Rev Endocrinol       Date:  2010-04-27       Impact factor: 43.330

Review 3.  Understanding the role of gut microbiome in metabolic disease risk.

Authors:  Yolanda Sanz; Marta Olivares; Ángela Moya-Pérez; Carlo Agostoni
Journal:  Pediatr Res       Date:  2014-10-14       Impact factor: 3.756

Review 4.  Gut Microbiota and Bone Health.

Authors:  Darin Quach; Robert A Britton
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

5.  Alterations of the Gut Microbiota in Hashimoto's Thyroiditis Patients.

Authors:  Fuya Zhao; Jing Feng; Jun Li; Lei Zhao; Yang Liu; Huinan Chen; Ye Jin; Biqiang Zhu; Yunwei Wei
Journal:  Thyroid       Date:  2018-02-01       Impact factor: 6.568

6.  An obesity-associated gut microbiome with increased capacity for energy harvest.

Authors:  Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

7.  Dysbiosis of Gut Microbiota (DOGMA)--a novel theory for the development of Polycystic Ovarian Syndrome.

Authors:  Kelton Tremellen; Karma Pearce
Journal:  Med Hypotheses       Date:  2012-04-27       Impact factor: 1.538

Review 8.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Authors: 
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

Review 9.  Human Microbiome as an Approach to Personalized Medicine.

Authors:  Hanieh-Sadat Ejtahed; Shirin Hasani-Ranjbar; Bagher Larijani
Journal:  Altern Ther Health Med       Date:  2017-11       Impact factor: 1.305

Review 10.  Experimental design and quantitative analysis of microbial community multiomics.

Authors:  Himel Mallick; Siyuan Ma; Eric A Franzosa; Tommi Vatanen; Xochitl C Morgan; Curtis Huttenhower
Journal:  Genome Biol       Date:  2017-11-30       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.